Cargando…
Integrative systems medicine approaches to identify molecular targets in lymphoid malignancies
Although survival rates for lymphoproliferative disorders are steadily increasing both in the US and in Europe, there is need for optimizing front-line therapies and developing more effective salvage strategies. Recent advances in molecular genetics have highlighted the biological diversity of lymph...
Autores principales: | Frazzi, Raffaele, Auffray, Charles, Ferrari, Angela, Filippini, Perla, Rutella, Sergio, Cesario, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007715/ https://www.ncbi.nlm.nih.gov/pubmed/27580852 http://dx.doi.org/10.1186/s12967-016-1018-2 |
Ejemplares similares
-
Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies
por: Pittari, Gianfranco, et al.
Publicado: (2015) -
Granulocyte transfusions in children and adults with hematological malignancies: benefits and controversies
por: Cugno, Chiara, et al.
Publicado: (2015) -
Cellular and Molecular Targets of Resveratrol on Lymphoma and Leukemia Cells
por: Frazzi, Raffaele, et al.
Publicado: (2017) -
SIRT1 in Secretory Organ Cancer
por: Frazzi, Raffaele
Publicado: (2018) -
BIRC3 and BIRC5: multi‐faceted inhibitors in cancer
por: Frazzi, Raffaele
Publicado: (2021)